Zhitong Finance App News, Jianshi Technology-B (09877.HK) announced that recently, one of the core products independently developed by the company, the JensClip Transcatheter Valve Repaire System (JensClip) has obtained registration approval from the National Drug Administration (NMPA). The company is actively promoting the commercialization and clinical application of this product in mainland China and other markets, and continues to advance its global layout.

Zhitongcaijing · 1d ago
Zhitong Finance App News, Jianshi Technology-B (09877.HK) announced that recently, one of the core products independently developed by the company, the JensClip Transcatheter Valve Repaire System (JensClip) has obtained registration approval from the National Drug Administration (NMPA). The company is actively promoting the commercialization and clinical application of this product in mainland China and other markets, and continues to advance its global layout.